PURPOSE To determine whether whole-brain acetazolamide-induced changes in regional
cerebral blood volume (rCBV) can be assessed on a conventional gradient 1.5-T MR system …

PURPOSE We examined age-related changes in baseline regional cerebral blood volume
(rCBV) and response to acetazolamide stimulation by using dynamic contrast-enhanced MR …

PURPOSE To investigate cerebral vasodilatory capacity by acetazolamide challenge in
healthy subjects and in patients with chronic occlusive cerebrovascular disease by using …

Abstracts The acetazolamide (ACZ) test is performed to evaluate the decrease in cerebral
perfusion pressure (CPP) by investigation of vasomotor reactivity (VMR). Our aim was to …

Purpose To develop a quantitative MRI method to estimate cerebrovascular reactivity (CVR)
in mice. Methods We described an MRI procedure to measure cerebral vasodilatory …

In patients with cerebrovascular disease the acetazolamide (ACZ) test is performed to
evaluate the decrease in cerebral perfusion pressure (CPP) through the investigation of the …

BACKGROUND AND PURPOSE: Measuring cerebrovascular reactivity with the use of
vasodilatory stimuli, such as acetazolamide, is useful for chronic cerebrovascular steno …

Objective: Dynamic susceptibility contrast (DSC) enhanced MRI was used to study relative
cerebral blood volume (rCBV). Materials and Methods: We examined 15 healthy subjects …

Abstract Changes in cerebral blood flow (CBF) induced by Acetazolamide (ACZ) were
measured using dynamic susceptibility contrast MRI (DSC‐MRI) with both spin echo (SE) …

Cerebral vasodilatory testing provides an important measure of both the hemodynamic
significance of arterial occlusive disease and the adequacy of collateral pathways. This …